Thymic carcinoma other imaging findings: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Thymic carcinoma}} | {{Thymic carcinoma}} | ||
{{CMG}}; {{AE}} {{AL}} | {{CMG}}; {{AE}} {{AL}}{{PSD}} | ||
==Overview== | |||
Other imaging studies for thymic carcinoma include FDG PET scan. | |||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
===FDG PET=== | ===FDG PET=== |
Revision as of 01:02, 4 January 2016
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma other imaging findings On the Web |
American Roentgen Ray Society Images of Thymic carcinoma other imaging findings |
Risk calculators and risk factors for Thymic carcinoma other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]Parminder Dhingra, M.D. [3]
Overview
Other imaging studies for thymic carcinoma include FDG PET scan.
Other Imaging Findings
FDG PET
FDG (Fludeoxyglucose) PET is a useful image study that allows differentiation between a thymoma and thymic carcinoma. The standarized uptake value (SUV) in the FDG PET is much higher for the thymic carcinoma, with a high sensitivity (84.6%) and specificity (92.3%)[1]